Disease and Therapy Review: Hepatitis B

• Publication date: February 2012

The Hepatitis B Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the hepatitis B market, as well as sales of leading drugs and therapies and future therapies are provided. D...

The Hepatitis B Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the hepatitis B market, as well as sales of leading drugs and therapies and future therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.  

Therapy Industry in Africa

I. OVERVIEW
General description of the condition
Risk factors
Disease progression and symptoms
Chronic infection
II. INCIDENCE, PREVALENCE AND MORTALITY
Incidence trends
Incidence Table (Canada, U.S., France, Germany, Italy, Spain, UK, China, Latin America, Worldwide)
Prevalence Table (Canada, U.S., Mexico, Italy, Spain, UK, China, India, Japan, Worldwide)
Mortality Table (U.S., China, Europe, Africa, the Americas, Eastern Mediterranean, Southeast Asia, Western Pacific Worldwide)
III. DIAGNOSIS
Diagnostic markers
IV. TREATMENT
Vaccination
Treatment of acute infection
Treatment of chronic infection
V. DOSING AND TREATMENT COSTS
Vaccination
Chronic infection
VI. MARKET SIZE
Sales information for key pharmaceuticals
VII. FUTURE THERAPIES
VIII. COMMENTS
IX. REFERENCES/RESOURCES